How to Manage Batch Release Testing for Importers in China: 2026 Guide

Date:

Share post:






How to Manage Batch Release Testing for Importers in China: 2026 Guide


How to Manage Batch Release Testing for Importers in China: 2026 Guide

China Market Access Series | ChinaGateway360.com | Updated 2026

1. What Is Batch Release Testing?

Batch release testing is the process of sampling and testing individual production lots (batches) of imported goods before they are released into the Chinese market. Unlike type testing — which certifies that a product design meets standards — batch release testing verifies that each production batch continues to meet the same quality and safety standards before being sold to consumers.

For importers in China, batch release testing bridges the gap between initial certification and ongoing market compliance. A product may have passed CCC certification with flying colours, but subsequent production batches could introduce variations in materials, components, or manufacturing processes that compromise safety. Batch release testing catches these variations before they reach the customer.

Core Principle: One batch passed = one batch sold. Each production batch must be independently verified before market release. This is not a one-time exercise but a continuous quality assurance obligation.

Batch release testing is mandated under several Chinese regulatory frameworks depending on the product category:

2.1 Product Quality Law of the PRC

The overarching Product Quality Law (latest revision 2018) imposes a general obligation on producers and sellers to ensure product quality meets specified standards. Article 12 states that products must be “safe for human health and property.” Batch release testing is the practical mechanism for demonstrating compliance with this obligation on an ongoing basis.

2.2 CCC Certification Requirements

For products covered by CCC certification, the certification body requires the manufacturer to conduct routine batch release testing as a condition of maintaining the certificate. The specific testing requirements are outlined in the CCC Implementation Rules for each product category. Key obligations include:

  • Testing at frequency specified in the product Implementation Rules (typically every batch or every Nth batch)
  • Conducting tests in accordance with the relevant GB standards
  • Maintaining test records for at least 5 years
  • Reporting non-conformities to the certification body within a specified timeframe

2.3 Sector-Specific Regulations

Certain industries have additional batch release testing requirements:

  • Food contact materials — GB 4806 series requires batch testing for migration limits
  • Cosmetics and personal care — NMPA requires batch testing for microbiological safety
  • Medical devices — NMPA requires batch release testing per product registration standards
  • Battery products — GB 31241 requires batch testing for lithium battery safety
  • Toys and children’s products — GB 6675 series requires batch testing for mechanical and chemical safety

2.4 Customs Supervision

Chinese customs (General Administration of Customs, GAC) may perform random batch inspections on imported goods. If customs selects your shipment for inspection, they test samples against applicable GB standards. A failed customs inspection can result in:

  • Shipment detention or destruction
  • Fines and administrative penalties
  • Enhanced customs surveillance (every shipment inspected, rather than random)
  • Blacklisting of the importer

3. The Batch Release Testing Process Step by Step

Step 1: Define the Batch

Clearly define what constitutes a “batch” for each product. A batch is typically defined by:

  • Production date — All units produced within a continuous production run (e.g., one shift, one day)
  • Production line — Units from different lines are separate batches
  • Raw material lot — If a new material lot is introduced, a new batch starts
  • Maximum batch size — Some regulations specify maximum batch sizes (e.g., 50,000 units for certain electronics)

Step 2: Determine Sampling Plan

Select a sampling methodology (see Section 6 below) that determines how many units from each batch are tested. The sampling plan must be documented and justifiable.

Step 3: Take Samples

Physical samples are drawn from the batch. Requirements include:

  • Samples must be taken randomly across the entire batch
  • Samples must be sealed and labelled with batch number, date, and sampler identity
  • A chain of custody record must be maintained from sampling point to testing lab
  • Samples must be representative — include units from the start, middle, and end of production

Step 4: Conduct Testing

Samples are tested against the applicable standards. Tests may include:

  • Safety tests — Dielectric strength, leakage current, grounding continuity
  • Performance tests — Functional verification, energy consumption
  • Material tests — Chemical composition, migration limits
  • Dimensional checks — Sample dimensions within specified tolerances
  • Marking and labelling verification — Check correctness and legibility

Step 5: Evaluate Results

Compare test results against the acceptance criteria defined in the sampling plan. Decisions:

  • Pass — The batch is released to the Chinese market
  • Conditional pass — Minor non-conformities that do not affect safety; batch released with corrective actions required for the next batch
  • Fail — Batch is held, quarantined, and subject to corrective actions or disposal

Step 6: Document and Retain Records

Maintain complete records for each batch, including:

  • Batch identification and size
  • Sampling plan and rationale
  • Sample IDs and chain of custody
  • Test reports from a CNAS-accredited lab
  • Pass/fail decision and rationale
  • Release authorisation (signed by qualified personnel)
  • If failed: corrective action report and disposition decision

Records must be retained for at least 5 years (or longer for certain product categories) and must be made available to regulators upon request.

4. Products That Require Batch Release Testing

While batch release testing is a best practice for all imported products, it is legally required for the following categories:

Product Category Regulatory Basis Testing Frequency
CCC-certified electrical products CCC Implementation Rules Every batch or per defined sampling interval
Food contact materials & articles GB 4806 series Every batch
Children’s toys GB 6675 series Every batch
Cosmetics Cosmetics Supervision and Administration Regulation Every batch
Medical devices NMPA regulations Every batch
Batteries (lithium-ion) GB 31241 Per defined sampling plan
Motor vehicle parts CCC Implementation Rules for auto parts Every batch
Pressure vessels Special Equipment Safety Law Every batch
⚠ Note: Even for products where batch release testing is not legally mandatory, Chinese e-commerce platforms (Tmall, JD.com) and major retailers (Suning, GOME) increasingly require proof of batch testing as part of their supplier qualification process. If you cannot produce batch test reports, you may be excluded from these sales channels.

5. Building a Batch Release Testing Plan

A well-structured batch release testing plan should include:

  1. Product identification — Product name, model numbers, SKU codes
  2. Applicable standards — List of GB standards and test methods with version dates
  3. Batch definition — Criteria for defining a batch (production time, quantity, material lot)
  4. Sampling plan — Statistical basis, sample size, acceptance criteria
  5. Test parameters — Specific tests to be performed on each batch
  6. Lab qualification — Lab must be CNAS + CMA accredited for each test parameter
  7. Documentation requirements — Records to be created and retention period
  8. Non-conformance procedure — Steps to follow when a batch fails
  9. Roles and responsibilities — Who is responsible for sampling, testing, evaluation, release
  10. Review and update cycle — When and how the plan is revised
Template Note: Your batch release testing plan should be a living document, reviewed at least annually and updated whenever there is a change in product design, manufacturing process, or applicable standards.

6. Sampling Methodologies

Choosing the right sampling methodology is critical to both cost-effectiveness and compliance.

6.1 Normal Inspection (ANSI/ASQ Z1.4 / GB/T 2828.1)

The most common approach, based on the internationally recognised GB/T 2828.1-2012 (identical to ISO 2859-1). Key parameters:

  • Inspection level — Level II (normal) is most common; Level I for reduced inspection; Level III for tightened
  • AQL (Acceptable Quality Limit) — Typically 0.65% for safety-critical items, 1.0%–2.5% for general quality
  • Sample size code letter — Determined by batch size and inspection level

6.2 Reduced Inspection

When a supplier has a strong track record (e.g., 10+ consecutive batches passed), the sampling frequency may be reduced. Reduced inspection uses a smaller sample size but has stricter switching rules — a single failure triggers a return to normal inspection.

6.3 Tightened Inspection

When a supplier has shown quality problems, the sampling frequency is increased. This means larger sample sizes and stricter acceptance criteria (lower AQL).

6.4 Zero-Defect Sampling

For high-risk products (medical devices, children’s products), China sometimes requires c=0 sampling plans where any non-conforming unit in the sample results in batch rejection. This is the strictest approach and significantly increases the cost of batch release testing.

Batch Size Sample Size (Normal II) Sample Size (Tightened III)
2–8 2 3
9–15 3 5
16–25 5 8
26–50 8 13
51–90 13 20
91–150 20 32
151–280 32 50
281–500 50 80
501–1,200 80 125
1,201–3,200 125 200
3,201–10,000 200 315

7. Selecting a Testing Lab for Batch Release

Batch release testing must be performed by a CNAS + CMA accredited laboratory whose accreditation scope covers the specific test standards. Options include:

  • In-house lab — If your Chinese subsidiary or factory has a CNAS-accredited lab, you can conduct batch testing internally. The lab must meet ISO 17025 requirements and maintain its own proficiency testing programme.
  • Third-party commercial lab — Most importers outsource to labs like SGS, Intertek, Bureau Veritas, or TÜV. These labs offer batch testing services with standard turnaround times of 5–15 business days.
  • Government-designated lab — For CCC-related batch testing, the same CNCA-designated labs that handled your type testing are also qualified for batch testing. They tend to have deeper knowledge of product-specific requirements.

8. Costs and Budgeting

Batch release testing costs should be factored into your ongoing cost of goods sold:

Cost Component Typical Range (USD per batch)
Sampling and logistics $100–$500
Safety testing (per standard) $500–$2,000
EMC testing (if required) $800–$3,000
Chemical/material testing $300–$1,500
Performance testing $200–$1,000
Report issuance $50–$200
Typical total per batch $1,000–$8,000
💰 Budgeting Strategy: Plan for 1–3% of the wholesale value of each batch to cover testing costs. For high-volume low-value products, consider reducing the test scope for routine batches while performing full testing on every Nth batch.

9. Handling Test Failures

When a batch fails release testing, follow this structured protocol:

  1. Immediate quarantine — Segregate the failed batch with clear “HOLD — NOT FOR SALE” labelling
  2. Notification — Inform relevant stakeholders (supplier, certification body if CCC product, importer)
  3. Root cause analysis — Determine why the batch failed (material change? process drift? operator error?)
  4. Corrective action — Implement corrective measures to prevent recurrence
  5. Disposition of failed batch — Options include rework, downgrading, return to supplier, or destruction
  6. Re-testing — Once corrective actions are in place, test a new sample from the corrected batch
  7. Documentation — Record the entire failure investigation and corrective action process
⚠ Regulatory Reporting: For certain product categories (medical devices, food contact materials, children’s toys), batch failure must be reported to the relevant regulatory authority within a specified timeframe (typically 5–15 business days). Failure to report can result in fines of up to 3x the value of the affected products.

10. Common Pitfalls

  • Underestimating the cost burden — Batch testing is an ongoing cost, not a one-time expense. Budget accordingly.
  • Using the wrong sampling plan — An inadequate sampling plan (too few samples) gives false confidence. A plan that is too strict drives up costs unnecessarily.
  • Poor record-keeping — Chinese regulators can request batch release records going back years. If you cannot produce them, the assumption is that testing was not performed.
  • Supplier not informed — Your supplier must understand that their production batches are independently tested. Some suppliers cut corners when they are not being monitored.
  • Failing to distinguish between type testing and batch testing — Type testing does not cover batch-to-batch variation. Even if your product passed CCC certification, each production batch must be independently verified.
  • Ignoring the customs inspection risk — If customs selects your shipment and your internal batch testing records are not in order, you face detention and penalties.
📌 Bottom Line for 2026: Batch release testing is the unsung hero of China market access for importers. While type certification gets the attention, it’s the consistent application of batch release testing that protects your brand, your customers, and your regulatory standing. Invest in a robust testing plan, maintain impeccable records, and treat each batch as if it will be audited — because in China, it very well might be.


Related articles

How a Foreign Biotech Startup Entered China’s Precision Medicine Market: Case Study

How a Foreign Biotech Startup Entered China's Precision Medicine Market: Case Study In 2023, NovaOnco Therapeutics, a US-based AI biotech startup, exe

How Legend Biotech Secured FDA Approval for CAR-T Therapy: Case Study

How Legend Biotech Secured FDA Approval for CAR-T Therapy: A China Biotech Case Study This case study examines how Legend Biotech (传奇生物, Legend Biotec

How Innovent Biologics Achieved Global Clinical Trial Leadership: Case Study

How Innovent Biologics Achieved Global Clinical Trial Leadership: Case Study body{font-family:'Segoe UI',Tahoma,Geneva,Verdana,sans-serif;line-height:

How BeiGene Built a Billion-Dollar Biotech in China: Case Study

How BeiGene Built a Billion-Dollar Biotech in China: Case Study How BeiGene Built a Billion-Dollar Biotech in China: Case Study The story of BeiGene's